BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 4320551)

  • 1. Reactivity of radioiodinated serum antibody from Burkitt's lymphoma and nasopharyngeal carcinoma patients against culture lines derived from Bukrkitt's lymphoma.
    Inoue M; Klein G
    Clin Exp Immunol; 1970 Jul; 7(1):39-50. PubMed ID: 4320551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cell membrane receptor of cultured cells derived from nasopharyngeal carcinoma, Burkitt's lymphoma and infectious mononucleosis].
    Nishioka K; Tachibana T; Hirayama T; De Thé G; Klein G
    Nihon Ishikai Zasshi; 1971 Jun; 65(11):1398-406. PubMed ID: 4326465
    [No Abstract]   [Full Text] [Related]  

  • 3. Epstein-Barr virus in Burkitt's lymphoma and nasopharyngeal carcinoma. Antibodies to EBV associated membrane and viral capsid antigens in Burkitt lymphoma patients.
    Gunvén P; Klein G; Henle G; Henle W; Clifford P
    Nature; 1970 Dec; 228(5276):1053-6. PubMed ID: 4320656
    [No Abstract]   [Full Text] [Related]  

  • 4. [Titer of antibodies against Burkitt's lymphoma virus in Burkitt's lymphoma and other diseases].
    Gunven P
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1972; 65(9):228-32. PubMed ID: 4353758
    [No Abstract]   [Full Text] [Related]  

  • 5. Smooth muscle antibody in Burkitt's lymphoma and in nasopharyngeal carcinoma.
    Lamelin JP; Williams EH; Souissi T; De-Thé G; Gabbiani G
    Clin Exp Immunol; 1977 Apr; 28(1):157-62. PubMed ID: 193662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasopharyngeal carcinoma and Burkitt's lymphoma in a Canadian family. I. HLA typing, EBV antibodies and serum immunoglobulins.
    Joncas JH; Rioux E; Wastiaux JP; Leyritz M; Robillard L; Menezes J
    Can Med Assoc J; 1976 Nov; 115(9):858-60. PubMed ID: 186168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definition of an antigenic system associated with Burkitt's lymphoma.
    Oettgen HF; Aoki T; Geering G; Boyse EA; Old LJ
    Cancer Res; 1967 Dec; 27(12):2532-4. PubMed ID: 4170384
    [No Abstract]   [Full Text] [Related]  

  • 8. [EB virus-associated tumors-opportunistic B cell lymphoma, Burkitt's lymphoma, nasopharyngeal carcinoma].
    Mizuno F
    Nihon Rinsho; 1989 Feb; 47(2):481-6. PubMed ID: 2542671
    [No Abstract]   [Full Text] [Related]  

  • 9. Direct membrane immunofluorescence reaction of Burkitt's lymphoma cells in culture.
    Goldstein G; Klein G; Pearson G; Clifford P
    Cancer Res; 1969 Apr; 29(4):749-52. PubMed ID: 4180347
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunological study of nasopharyngeal carcinoma].
    Tachibana T
    Nihon Ishikai Zasshi; 1971 Jun; 65(11):1387-98. PubMed ID: 4327018
    [No Abstract]   [Full Text] [Related]  

  • 11. The Epstein-Barr Virus (EBV) in Burkitt's lymphoma and nasopharyngeal carcinoma.
    Henle W; Henle G
    Ann Clin Lab Sci; 1974; 4(2):109-14. PubMed ID: 4362218
    [No Abstract]   [Full Text] [Related]  

  • 12. [Problems posed by the immunological properties common to Burkitt's lymphoma and cancer. Means of resolving them].
    De-Thé G
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):767-88. PubMed ID: 4340546
    [No Abstract]   [Full Text] [Related]  

  • 13. [Burkitt's lymphoma].
    Gombos F; Serpico R; Femiano F
    Arch Stomatol (Napoli); 1984; 25(4):329-38. PubMed ID: 6100729
    [No Abstract]   [Full Text] [Related]  

  • 14. Surface antigens on lymphoblastoid cells derived from nasopharyngeal carcinoma.
    de Thé G; de Schryver A; Klein G
    Clin Exp Immunol; 1970 Aug; 7(2):161-71. PubMed ID: 4320167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in antibody titer against the EBV-associated membrane antigen complex in Burkitt's lymphoma and nasopharyngeal carcinoma after local irradiation.
    Einhorn N; Klein G; Clifford P
    Cancer; 1970 Nov; 26(5):1013-21. PubMed ID: 4920396
    [No Abstract]   [Full Text] [Related]  

  • 16. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases.
    Meij P; Vervoort MB; Aarbiou J; van Dissel P; Brink A; Bloemena E; Meijer CJ; Middeldorp JM
    J Infect Dis; 1999 May; 179(5):1108-15. PubMed ID: 10191211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies against tumours.
    Br Med J; 1971 Nov; 4(5786):505-6. PubMed ID: 4331480
    [No Abstract]   [Full Text] [Related]  

  • 18. Epstein-Barr virus-related serology in Hodgkin's disease.
    Henle W; Henle G
    Natl Cancer Inst Monogr; 1973 May; 36():79-84. PubMed ID: 4355353
    [No Abstract]   [Full Text] [Related]  

  • 19. The clinical significance of immunological findings in Burkitt's lymphoma. (Epstein-Barr virus-associated antibodies/BCG treatment.
    Gunvén P
    Hamatol Bluttransfus; 1974; 14():129-32. PubMed ID: 4375070
    [No Abstract]   [Full Text] [Related]  

  • 20. Seroepidemiological studies on carcinoma of the nasopharynx.
    Lin TM; Yang CS; Chiou JF; Tu SM; Lin CC; Liu CH; Chen KP; Ito Y; Kawamura A; Hirayama T
    Cancer Res; 1973 Nov; 33(11):2603-8. PubMed ID: 4355974
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.